| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Immune Dysregulation in MPN
|
Barosi, Giovanni
|
|
2014
|
9 |
4 |
p. 331-339
|
artikel
|
| 2 |
Antiplatelet Therapy in the Management of Myeloproliferative Neoplasms
|
Alvarez-Larrán, Alberto
|
|
2014
|
9 |
4 |
p. 319-323
|
artikel
|
| 3 |
Back to Biology: New Insights on Inheritance in Myeloproliferative Disorders
|
Braunstein, Evan M.
|
|
2014
|
9 |
4 |
p. 311-318
|
artikel
|
| 4 |
Chronic Myelomonocytic Leukemia Prognostic Classification and Management: Evidence Base and Current Practice
|
Selimoglu-Buet, Dorothée
|
|
2014
|
9 |
4 |
p. 301-310
|
artikel
|
| 5 |
Controversies in Multiple Myeloma: to Transplant or Not?
|
Preeshagul, Isabel Ruth
|
|
2014
|
9 |
4 |
p. 360-367
|
artikel
|
| 6 |
Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
|
Biran, Noa
|
|
2014
|
9 |
4 |
p. 368-378
|
artikel
|
| 7 |
Epidemiology of MPN: What Do We Know?
|
Anderson, L. A.
|
|
2014
|
9 |
4 |
p. 340-349
|
artikel
|
| 8 |
I Walk the Line: How to Tell MDS From Other Bone Marrow Failure Conditions
|
Gondek, Lukasz P.
|
|
2014
|
9 |
4 |
p. 389-399
|
artikel
|
| 9 |
I Walk the Other Line: Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndromes
|
Gerds, Aaron T.
|
|
2014
|
9 |
4 |
p. 400-406
|
artikel
|
| 10 |
Lessons from the Atomic Bomb About Secondary MDS
|
Hata, Tomoko
|
|
2014
|
9 |
4 |
p. 407-411
|
artikel
|
| 11 |
Quality of Life in MPN Comes of Age as a Therapeutic Target
|
Scherber, Robyn M.
|
|
2014
|
9 |
4 |
p. 324-330
|
artikel
|
| 12 |
Resuscitating a Dying Marrow: the Role of Hematopoietic Growth Factors
|
Pandita, Aakriti
|
|
2014
|
9 |
4 |
p. 412-420
|
artikel
|
| 13 |
Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
|
Yacoub, A.
|
|
2014
|
9 |
4 |
p. 350-359
|
artikel
|
| 14 |
Stopping Higher-Risk Myelodysplastic Syndrome in Its Tracks
|
Pollyea, Daniel A.
|
|
2014
|
9 |
4 |
p. 421-431
|
artikel
|
| 15 |
What We Mean When We Talk About MRD in Myeloma. A Review of Current Methods. Part 1 of a Two-Part Series
|
Ely, Scott
|
|
2014
|
9 |
4 |
p. 379-388
|
artikel
|
Tijdschrift beschrijving